Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)
Clinical trial NCT03033745 · COMPLETED
Trial details
- NCT number
- NCT03033745
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-12-14
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.